What is he best known for?
The fields of study he is best known for:
His main research concerns Cancer research, DNA methylation, Breast cancer, microRNA and Cancer.
His studies deal with areas such as MLH1, Gene expression profiling, Carcinoma, Estrogen receptor and PTEN as well as Cancer research.
Christopher C. Benz combines subjects such as Mutation, KRAS and BAP1 with his study of DNA methylation.
His Breast cancer research includes themes of Basic fibroblast growth factor and Angiogenesis, Angiogenin.
His microRNA research is multidisciplinary, relying on both Oncogene, Molecular biology, RNA interference, Histone deacetylase inhibitor and ErbB.
His biological study spans a wide range of topics, including Computational biology and Immunology.
His most cited work include:
- Comprehensive molecular portraits of human breast tumours (7253 citations)
- Comprehensive molecular characterization of human colon and rectal cancer (5012 citations)
- Integrated genomic analyses of ovarian carcinoma (4769 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Breast cancer, Cancer research, Internal medicine, Cancer and Oncology.
His research integrates issues of Surgical oncology, Gynecology, Bioinformatics and Pathology in his study of Breast cancer.
His Cancer research study combines topics in areas such as DNA methylation, Carcinogenesis, Oncogene, Immunology and microRNA.
The study incorporates disciplines such as Transcriptome, Gene and Pharmacology in addition to Cancer.
Christopher C. Benz has researched Oncology in several fields, including Disease and Hazard ratio.
Christopher C. Benz usually deals with Estrogen receptor and limits it to topics linked to Estrogen and Mammary gland.
He most often published in these fields:
- Breast cancer (46.41%)
- Cancer research (34.97%)
- Internal medicine (29.08%)
What were the highlights of his more recent work (between 2013-2021)?
- Breast cancer (46.41%)
- Oncology (23.20%)
- Internal medicine (29.08%)
In recent papers he was focusing on the following fields of study:
Breast cancer, Oncology, Internal medicine, Cancer research and Cancer are his primary areas of study.
Christopher C. Benz interconnects Pregnancy, Biopsy, Gynecology, Genotype and Hazard ratio in the investigation of issues within Breast cancer.
His work deals with themes such as Endocrine therapy, Tamoxifen, Tamoxifen therapy, Estrogen receptor and Disease, which intersect with Oncology.
The concepts of his Cancer research study are interwoven with issues in DNA methylation, Oncogene, microRNA, Gene and PTEN.
His DNA methylation research includes elements of DNA sequencing and Genomics.
His research in Cancer focuses on subjects like Transcriptome, which are connected to Phenotype, Adipocyte and Breast disease.
Between 2013 and 2021, his most popular works were:
- Comprehensive molecular characterization of gastric adenocarcinoma (2822 citations)
- Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
- Comprehensive molecular characterization of urothelial bladder carcinoma (1756 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Cancer research, Gene, DNA methylation, microRNA and Cancer.
His Melanoma study in the realm of Cancer research interacts with subjects such as CDH1.
His Gene study integrates concerns from other disciplines, such as Bioinformatics and Adenocarcinoma.
His DNA methylation research incorporates elements of Mutation, Genome, Genomics, Liver cancer and Transforming growth factor beta.
His work in microRNA addresses issues such as Oncogene, which are connected to fields such as Exon, Adenocarcinoma of the lung, Molecular biology and MET Exon 14 Skipping Mutation.
Breast cancer is the focus of his Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
